Finance

Lists
Why is ASPN up 3.16%?
Dive Deeper
ASPN:NYSE
Aspen Aerogels Inc
$5.87
+3.16%
(+0.18) 1D
$5.76
-1.87% (-0.11)
Pre-market
Closed: Oct 6, 4:00:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ASPN...
Open
$5.76
High
$5.92
Low
$5.69
Mkt. cap
487.14M
Avg. vol.
882.16K
Volume
532.00
52-wk high
$9.35
52-wk low
$2.30
EPS
-$1.53
Beta
3.06
Shares outstanding
82.99M
No. of employees
854
Open
$5.76
High
$5.92
Low
$5.69
Mkt. cap
487.14M
Avg. vol.
882.16K
Volume
532.00
52-wk high
$9.35
52-wk low
$2.30
EPS
-$1.53
Beta
3.06
Shares outstanding
82.99M
No. of employees
854
News stories
From web sources and news partners
About Aspen Aerogels Inc
CEODonald R. Young
Employees854
Founded2001
HeadquartersNorthborough, Massachusetts, United States
SectorSpeciality chemicals
Websiteaerogel.com
Analyst ratings
Based on 4 analysts giving stock ratings to ASPN in the past 3 months
Buy
Buy
3
Hold
0
Sell
1
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ASPN in the last 3 months.
Highest
Current $5.87
$9.00 (+53.32%)
Average
$7.25 (+23.51%)
Lowest
$5.00 (-14.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eric Stine
Craig-Hallum
Buy
Reiterated
-
-
09/25/2026
David Anderson
Barclays
Sell
Maintained
$5.00
-14.8%
08/10/2026
Ryan Pfingst
B. Riley Securities
Buy
Maintained
$9.00
+53.3%
08/07/2026
Chip Moore
Roth MKM
Buy
Maintained
$7.75
+32%
08/07/2026
Itay Michaeli
TD Cowen
Buy
Maintained
$6.00
+2.2%
02/26/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.22 / -$0.20
-7.71%miss
Revenue / Est. (USD)
49.85M / 42.42M
+17.51%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
73.02M
41.34M
37.88M
49.85M
Cost of goods sold
52.22M
42.17M
33.61M
41.27M
Cost of revenue
52.22M
42.17M
33.61M
41.27M
Research and development expenses
2.49M
2.80M
2.72M
3.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20.08M
21.69M
21.96M
19.94M
Operating expense
22.58M
24.48M
24.68M
23.14M
Total operating expenses
74.80M
66.65M
58.29M
64.40M
Operating income
-1.78M
-25.31M
-20.41M
-14.56M
Other non operating income
581.00K
75.00K
41.00K
5.00K
EBT including unusual items
-5.74M
-73.01M
-23.94M
-22.64M
EBT excluding unusual items
-4.17M
-27.94M
-23.52M
-17.33M
Income tax expense
594.00K
-97.00K
-253.00K
619.00K
Effective tax rate
-10.35%
0.13%
1.06%
-2.73%
Other operating expenses
-
-
-
-
Net income
-6.33M
-72.91M
-23.69M
-23.26M
Net profit margin
-8.67%
-176.38%
-62.54%
-46.67%
Earnings per share
-0.06
-0.34
-0.28
-0.22
Interest and investment income
-
-
-
-
Interest expense
-2.97M
-2.70M
-3.15M
-2.78M
Net interest expenses
-2.97M
-2.70M
-3.15M
-2.78M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.61M
-19.34M
-15.02M
-10.26M
Gain or loss from assets sale
-
18.16M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps